| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.07 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |